Anthi Chalou presented her half-time review

On the 27th November 2025, Anthi Chalou presented her progress in her PhD studies in Malmö, Sweden.

This review marks the half-way point of completing her PhD studies, wherein she is exploring the mechanisms and cellular targets of immune checkpoint inhibition-elicited cardiovascular inflammation. By better understanding these mechanisms, new clinical strategies preserving the potent anti-tumor effects of immune checkpoint inhibition treatment while also mitigating negative cardiovascular effects may be developed.

Funded by the European Union under Grant Agreement No. 101115159.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.

© 2026 Bspecific. All rights reserved